USD 28.69 billion
Endometrial Cancer Market Size, Share, and Growth Analysis
Endometrial Cancer Market By Cancer Type (Endometrial carcinoma, Uterine sarcoma), By Treatment (Surgery, Chemotherapy), By Diagnosis Method (Biopsy, Pelvic Ultrasound), By Stage (Stage I, Stage II), By End Use, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2202 |
Region:
Global |
Published Date: January, 2025
Pages:
157
|Tables:
63
|Figures:
75
Format -
Endometrial Cancer Market Insights
Global Endometrial Cancer Market size was valued at USD 28.69 billion in 2023 and is poised to grow from USD 30.1 billion in 2024 to USD 44.13 billion by 2032, growing at a CAGR of 4.9% during the forecast period (2025-2032).
The global endometrial cancer market is witnessing significant growth and advancements in the diagnosis, treatment, and management of the disease. Rising incidence rates of endometrial cancer, increasing awareness among individuals, and improved healthcare infrastructure are driving market growth.
Technological innovations in diagnostic tools, such as molecular profiling and genetic testing, have enabled accurate and personalized treatment approaches. Additionally, the development of targeted therapies, immunotherapies, and combination treatment modalities are further propelling market expansion.
Advancements in diagnostic techniques, such as genomic profiling and liquid biopsies, are enabling early detection and personalized treatment approaches. Additionally, targeted therapies and immunotherapies are gaining prominence, offering improved efficacy and reduced side effects compared to traditional treatments.
However, challenges such as high treatment costs, limited accessibility to advanced healthcare facilities, and the need for effective early detection methods remain important considerations in addressing the global burden of endometrial cancer.
US Endometrial Cancer Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
surgery
Fastest Growth
surgery
Growth Rate
4.9% CAGR
Global Endometrial Cancer Market by region
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Endometrial Cancer Market Segments Analysis
Global Endometrial Cancer Market is segmented by Cancer Type, Treatment, Diagnosis Method, Stage, End Use and region. Based on Cancer Type, the market is segmented into Endometrial carcinoma and Uterine sarcoma. Based on Treatment, the market is segmented into Surgery, Chemotherapy, Radiation therapy, Hormone therapy, Targeted therapy and Immunotherapy. Based on Diagnosis Method, the market is segmented into Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan and Other Diagnosis Methods. Based on Stage, the market is segmented into Stage I, Stage II, Stage III and Stage IV. Based on End Use, the market is segmented into Hospitals, Cancer centers and Ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Endometrial Cancer Market Analysis By Cancer Type
Type I endometrial cancer, specifically endometrioid adenocarcinoma, represents the largest sector in the global endometrial cancer market. It accounts for the majority of diagnosed cases of endometrial cancer. Type I endometrial cancer is typically diagnosed at an early stage due to its characteristic symptoms, such as abnormal uterine bleeding, which prompts women to seek medical attention. Moreover, advancements in diagnostic techniques, such as endometrial biopsy and imaging modalities, have facilitated early detection and improved the overall survival rates for patients with type I endometrial cancer.
The fastest-growing sector in the global endometrial cancer market is type II endometrial cancer. Although less common, type II endometrial cancer is associated with a higher risk of recurrence and metastasis, necessitating aggressive treatment approaches. Research and clinical trials focusing on targeted therapies and novel treatment options for type II endometrial cancer are actively ongoing. The development of personalized medicine and immunotherapies has shown promising results in improving outcomes for patients with type II endometrial cancer. The growing understanding of the molecular and genetic characteristics of type II endometrial cancer is paving the way for more effective and tailored treatments, driving the growth of this sector in the global market.
Endometrial Cancer Market Analysis By Treatment
The largest sector in the global endometrial cancer market is likely to be surgery. Surgical intervention, particularly hysterectomy, is the primary treatment for endometrial cancer. It is often the first line of treatment for localized tumors that have not spread beyond the uterus. Surgery offers the potential for complete removal of the cancerous tissue and provides valuable information about the stage and grade of the cancer.
The fastest growing sector in the global endometrial cancer market is expected to be targeted therapy. Targeted therapies have shown promise in various types of cancers, including endometrial cancer. These therapies specifically target certain molecules or pathways involved in cancer growth, which can lead to more effective and less toxic treatments. Advancements in understanding the molecular and genetic characteristics of endometrial cancer have led to the development of targeted therapies that can specifically attack cancer cells while sparing healthy tissues. These therapies have the potential to improve outcomes and offer new treatment options for patients with advanced or recurrent endometrial cancer.
Global Endometrial Cancer Market by treatment type
To get detailed analysis on other segments, Request For Free Sample Report
Endometrial Cancer Market Regional Insights
North America holds a significant market share due to advanced healthcare infrastructure, rising incidence rates, and increasing adoption of innovative treatment options.
Europe follows suit with a focus on clinical research, robust regulatory frameworks, and growing awareness among healthcare professionals and patients.
The Asia-Pacific region witnesses a rising burden of endometrial cancer due to lifestyle changes, aging population, and limited access to healthcare.
Emerging economies in Latin America and the Middle East show growing market potential as healthcare infrastructure improves and awareness campaigns gain traction.
Global Endometrial Cancer Market by geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Endometrial Cancer Market Dynamics
Endometrial Cancer Market Drivers
Increasing Investment on Developing Healthcare Infrastructure
- One driver in the global endometrial cancer market is the increasing prevalence of endometrial cancer worldwide. Endometrial cancer is one of the most common gynecological cancers, and its incidence has been steadily rising over the years. The growing prevalence of risk factors such as obesity, hormonal imbalances, and diabetes contributes to the higher incidence of endometrial cancer. This increased prevalence drives the demand for effective diagnostic and therapeutic solutions, leading to market growth.
- Advancements in medical technology and improved screening methods also fuel the market, as they enable early detection and treatment of endometrial cancer, improving patient outcomes.
Endometrial Cancer Market Restraints
Lack of Accessibility and High Cost
- One restraint in the global endometrial cancer market is the high cost of treatment and limited healthcare access, especially in developing regions. The cost of endometrial cancer treatment, including surgeries, chemotherapy, and radiation therapy, can be substantial, placing a financial burden on patients. This restricts access to optimal care and therapies for many individuals, particularly those without adequate health insurance or resources.
- In some regions, there may be a lack of healthcare infrastructure, including diagnostic facilities and specialized healthcare professionals, further limiting timely and effective management of endometrial cancer. Addressing these challenges and improving affordability and accessibility to quality care are crucial for overcoming this restraint and improving patient outcomes globally.
Request Free Customization of this report to help us to meet your business objectives.
Endometrial Cancer Market Competitive Landscape
The global endometrial cancer market features a competitive landscape with several prominent players vying for market share. These companies are focused on developing targeted therapies, immunotherapies, and combination therapies to improve patient outcomes. Additionally, strategic collaborations, mergers, and acquisitions are common strategies employed by these players to strengthen their market position. With a strong emphasis on technological advancements and personalized medicine, the competitive landscape of the global endometrial cancer market remains dynamic and driven by constant innovation.
Top Players in Endometrial Cancer Market
- GlaxoSmithKline plc (GSK) (United Kingdom)
- Merck & Co., Inc. (United States)
- AstraZeneca plc (United Kingdom)
- Novartis AG (Switzerland)
- Pfizer Inc. (United States)
- F. Hoffmann-La Roche AG (Switzerland)
- Bristol Myers Squibb Company (United States)
- Karyopharm Therapeutics Inc. (United States)
- Siemens Healthineers AG (Germany)
- Takeda Pharmaceutical Company Limited (Japan)
- Incyte Corporation (United States)
- Context Therapeutics Inc. (United States)
- Evergreen Therapeutics, Inc. (United States)
- Sysmex Corporation (Japan)
- Gilead Sciences, Inc. (United States)
- Johnson & Johnson (United States)
- AbbVie Inc. (United States)
- Sanofi S.A. (France)
Endometrial Cancer Market Recent Developments
- In October 2022, Sysmex Corporation announced the approval of an application for a partial change to the manufacturing and marketing approval in Japan of its gene amplification reagent LYNOAMP CK19, expanding its amplification to cervical cancer and endometrial cancer. This reagent is marketed as a lymph node metastasis test reagent for breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer.
Endometrial Cancer Key Market Trends
- The market is witnessing collaborations and partnerships between pharmaceutical companies and research institutions to accelerate drug development and clinical trials. Overall, these trends are shaping the endometrial cancer market towards improved diagnostics, novel therapies, and better patient outcomes.
Endometrial Cancer Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global endometrial cancer market holds promising prospects for the future. Advances in technology and medical research have paved the way for the development of innovative treatment modalities, such as targeted therapies and immunotherapies, that show potential in improving patient outcomes. Additionally, precision medicine approaches, including molecular profiling and genetic testing, offer personalized treatment options for patients based on their unique genetic makeup and tumor characteristics. Furthermore, ongoing research and clinical trials focusing on novel biomarkers, early detection methods, and minimally invasive surgical techniques hold promise for early diagnosis and improved survival rates.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 28.69 billion |
| Market size value in 2032 | USD 44.13 billion |
| Growth Rate | 4.9% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Endometrial Cancer Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Endometrial Cancer Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Endometrial Cancer Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Endometrial Cancer Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Endometrial Cancer Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Endometrial Cancer Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Endometrial Cancer Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
